Abstract
Brain stimulation therapies for the treatment of neuropsychiatric and neurodegenerative diseases [1] have become of major interest to various global communities. Neuropsychiatric and neurodegenerative diseases associated with insulin resistance are expected to affect millions of people by the year 2050 [2,3]. The treatment by brain stimulation therapies in the early stages of neuropsychiatric conditions may allow stabilization or reversal of various conditions such as depression, schizophrenia, bipolar disorders, behavioural, cognition and memory disorders. Brain stimulation therapies include Electroconvulsive Therapy (ECT), Vagus Nerve Stimulation (VNS), Deep Brain Stimulation (DBS), Transcranial Direct Current Stimulation (tDCS) and repetitive transcranial magnetic stimulation. Brain stimulation therapies such as ECT should be reassessed with relevance
| Original language | English |
|---|---|
| Pages (from-to) | 1 |
| Number of pages | 1 |
| Journal | International Journal of Genomics and Data Mining |
| Volume | 2018 |
| Issue number | 02 |
| Publication status | Published - 12 Jul 2018 |